The IDEP concept is the active incretin hormone levels, especially GLP‐1, can be enriched through modifications in the diet, physical exercise and pharmacotherapy, which is further protected from degradation by use of DPP‐4 inhibitors, thereby offers good glycaemic control in patients with T2DM. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.